204 related articles for article (PubMed ID: 22166528)
1. Association of neutrophil/lymphocyte ratio with long-term mortality after ST elevation myocardial infarction treated with primary percutaneous coronary intervention.
Shen XH; Chen Q; Shi Y; Li HW
Chin Med J (Engl); 2010 Dec; 123(23):3438-43. PubMed ID: 22166528
[TBL] [Abstract][Full Text] [Related]
2. [Increased postprocedural neutrophil count is an independent predictive factor of poor prognosis in acute ST elevation myocardial infarction patients treated with percutaneous coronary intervention].
He R; Yang ZH; Li HY; Guo LJ; Zhang FC; Niu J; Zhang YZ; Wang GS; Gao W
Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Jan; 37(1):44-8. PubMed ID: 19671351
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of adiponectin as a predictor of all cause mortality in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
Lindberg S; Pedersen SH; Møgelvang R; Bjerre M; Frystyk J; Flyvbjerg A; Galatius S; Jensen JS
Am J Cardiol; 2012 Feb; 109(4):492-6. PubMed ID: 22105783
[TBL] [Abstract][Full Text] [Related]
4. The neutrophil to lymphocyte ratio was associated with impaired myocardial perfusion and long term adverse outcome in patients with ST-elevated myocardial infarction undergoing primary coronary intervention.
Sen N; Afsar B; Ozcan F; Buyukkaya E; Isleyen A; Akcay AB; Yuzgecer H; Kurt M; Karakas MF; Basar N; Hajro E; Kanbay M
Atherosclerosis; 2013 May; 228(1):203-10. PubMed ID: 23489347
[TBL] [Abstract][Full Text] [Related]
5. Relation of neutrophil/lymphocyte ratio to coronary flow to in-hospital major adverse cardiac events in patients with ST-elevated myocardial infarction undergoing primary coronary intervention.
Akpek M; Kaya MG; Lam YY; Sahin O; Elcik D; Celik T; Ergin A; Gibson CM
Am J Cardiol; 2012 Sep; 110(5):621-7. PubMed ID: 22608360
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of the neutrophil to lymphocyte ratio in predicting long-term mortality in ST segment elevation myocardial infarction.
Núñez J; Núñez E; Bodí V; Sanchis J; Miñana G; Mainar L; Santas E; Merlos P; Rumiz E; Darmofal H; Heatta AM; Llàcer A
Am J Cardiol; 2008 Mar; 101(6):747-52. PubMed ID: 18328833
[TBL] [Abstract][Full Text] [Related]
7. Time to treatment and three-year mortality after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction-a DANish Trial in Acute Myocardial Infarction-2 (DANAMI-2) substudy.
Maeng M; Nielsen PH; Busk M; Mortensen LS; Kristensen SD; Nielsen TT; Andersen HR;
Am J Cardiol; 2010 Jun; 105(11):1528-34. PubMed ID: 20494656
[TBL] [Abstract][Full Text] [Related]
8. Predictive value of plasma glucose level on admission for short and long term mortality in patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention.
Hoebers LP; Damman P; Claessen BE; Vis MM; Baan J; van Straalen JP; Fischer J; Koch KT; Tijssen JG; de Winter RJ; Piek JJ; Henriques JP
Am J Cardiol; 2012 Jan; 109(1):53-9. PubMed ID: 21944676
[TBL] [Abstract][Full Text] [Related]
9. Impact of multivessel coronary disease on one-year clinical outcomes and five-year mortality in patients with ST-elevation myocardial infarction undergoing percutaneous coronary intervention.
Lekston A; Tajstra M; Gąsior M; Gierlotka M; Pres D; Hudzik B; Trzeciak P; Kalarus Z; Poloński L; Zembala M
Kardiol Pol; 2011; 69(4):336-43. PubMed ID: 21523666
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and prognostic implications of ST-segment deviations from ambulatory Holter monitoring after ST-segment elevation myocardial infarction treated with either fibrinolysis or primary percutaneous coronary intervention (a Danish Trial in Acute Myocardial Infarction-2 Substudy).
Idorn L; Høfsten DE; Wachtell K; Mølgaard H; Egstrup K;
Am J Cardiol; 2007 Sep; 100(6):937-43. PubMed ID: 17826373
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of kidney function in patients with ST-elevation and non-ST-elevation acute myocardial infarction treated with percutaneous coronary intervention.
Seyfarth M; Kastrati A; Mann JF; Ndrepepa G; Byrne RA; Schulz S; Mehilli J; Schömig A
Am J Kidney Dis; 2009 Nov; 54(5):830-9. PubMed ID: 19592145
[TBL] [Abstract][Full Text] [Related]
12. Long-term prognosis of first myocardial infarction according to the electrocardiographic pattern (ST elevation myocardial infarction, non-ST elevation myocardial infarction and non-classified myocardial infarction) and revascularization procedures.
García-García C; Subirana I; Sala J; Bruguera J; Sanz G; Valle V; Arós F; Fiol M; Molina L; Serra J; Marrugat J; Elosua R
Am J Cardiol; 2011 Oct; 108(8):1061-7. PubMed ID: 21791326
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of neutrophil/lymphocyte ratio in patients with ST-elevated myocardial infarction undergoing primary coronary intervention: a prospective, multicenter study.
Kaya MG; Akpek M; Lam YY; Yarlioglues M; Celik T; Gunebakmaz O; Duran M; Ulucan S; Keser A; Oguzhan A; Gibson MC
Int J Cardiol; 2013 Sep; 168(2):1154-9. PubMed ID: 23219132
[TBL] [Abstract][Full Text] [Related]
14. Plasma B-type natriuretic peptide level can predict myocardial tissue perfusion in patients undergoing primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction.
Seo SM; Kim S; Chang K; Min J; Kim TH; Koh YS; Park HJ; Shin WS; Lee JM; Kim PJ; Chung WS; Seung KB
Coron Artery Dis; 2011; 22(6):405-10. PubMed ID: 21701385
[TBL] [Abstract][Full Text] [Related]
15. Value of early risk stratification using hemoglobin level and neutrophil-to-lymphocyte ratio in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Cho KH; Jeong MH; Ahmed K; Hachinohe D; Choi HS; Chang SY; Kim MC; Hwang SH; Park KH; Lee MG; Ko JS; Sim DS; Yoon NS; Yoon HJ; Hong YJ; Kim KH; Kim JH; Ahn Y; Cho JG; Park JC; Kang JC
Am J Cardiol; 2011 Mar; 107(6):849-56. PubMed ID: 21247535
[TBL] [Abstract][Full Text] [Related]
16. Prognostic utility of left ventricular end-diastolic pressure in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Planer D; Mehran R; Witzenbichler B; Guagliumi G; Peruga JZ; Brodie BR; Dudek D; Möckel M; Reyes SL; Stone GW
Am J Cardiol; 2011 Oct; 108(8):1068-74. PubMed ID: 21798494
[TBL] [Abstract][Full Text] [Related]
17. Relation between electrocardiographic ST-segment resolution and early and late outcomes after primary percutaneous coronary intervention for acute myocardial infarction.
Brodie BR; Stuckey TD; Hansen C; VerSteeg DS; Muncy DB; Moore S; Gupta N; Downey WE
Am J Cardiol; 2005 Feb; 95(3):343-8. PubMed ID: 15670542
[TBL] [Abstract][Full Text] [Related]
18. Blood glucose level on admission determines in-hospital and long-term mortality in patients with ST-segment elevation myocardial infarction complicated by cardiogenic shock treated with percutaneous coronary intervention.
Pres D; Gasior M; Strojek K; Gierlotka M; Hawranek M; Lekston A; Wilczek K; Tajstra M; Gumprecht J; Poloński L
Kardiol Pol; 2010 Jul; 68(7):743-51. PubMed ID: 20648428
[TBL] [Abstract][Full Text] [Related]
19. Serum B-type natriuretic peptide levels on admission predict not only short-term death but also angiographic success of procedure in patients with acute ST-elevation myocardial infarction treated with primary angioplasty.
Grabowski M; Filipiak KJ; Karpinski G; Wretowski D; Rdzanek A; Huczek Z; Horszczaruk GJ; Kochman J; Rudowski R; Opolski G
Am Heart J; 2004 Oct; 148(4):655-62. PubMed ID: 15459597
[TBL] [Abstract][Full Text] [Related]
20. Comparison of prognostic value of epicardial blood flow and early ST-segment resolution after primary coronary angioplasty. ANIN--Myocardial Infarction Registry.
Kalińczuk Ł; Przyłuski J; Karcz M; Petryka J; Kaczmarska E; Bekta P; Kepka C; Kruk M; Pregowski J; Kadziela J; Deptuch T; Skwarek M; Cedro K; Ciszewski M; Debski A; Ciszewski A; Chmielak Z; Demkow M; Witkowski A; Ruzyłło W
Kardiol Pol; 2007 Jan; 65(1):1-10; discussion 11-2. PubMed ID: 17295155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
